| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.609 | 0.012 | 0.65 | Immunosuppressant | 0.65 0.008 CID_654 | CID_654 | |
| 0.61 | 0.018 | 0.61 | Thyroid hormone antagonist | 0.365 0.068 CID_135444498 | ||
| 0.574 | 0.004 | 0.574 | Butyrylcholinesterase inhibitor | |||
| 0.441 | 0.005 | 0.441 | Acetylcholinesterase inhibitor | |||
| 0.428 | 0.008 | 0.428 | Cholinergic | |||
| 0.321 | 0.029 | 0.744 | Anesthetic general | 0.744 0.003 CID_654 | CID_654 | |
| 0.287 | 0.004 | 0.287 | Phosphodiesterase 7B inhibitor | 0.255 0.005 CID_135444498 | ||
| 0.276 | 0.037 | 0.564 | RNA-directed DNA polymerase inhibitor | 0.306 0.03 CID_135444498 0.564 0.007 CID_654 | CID_654 | |
| 0.353 | 0.12 | 0.353 | Cyclophilin D inhibitor | 0.331 0.137 CID_135444498 | ||
| 0.288 | 0.104 | 0.505 | Calcium channel activator | 0.324 0.069 CID_135444498 0.505 0.005 CID_654 | CID_654 | |
| 0.203 | 0.041 | 0.4 | Phospholipase A2 inhibitor | 0.4 0.005 CID_654 | CID_654 | |
| 0.161 | 0.009 | 0.249 | Purinergic P2X2 antagonist | 0.117 0.022 CID_135444498 0.249 0.003 CID_654 | CID_654 | |
| 0.167 | 0.018 | 0.64 | Sphingosine 1-phosphate receptor 2 agonist | 0.64 0.002 CID_654 | CID_654 | |
| 0.225 | 0.08 | 0.434 | Hypolipemic | 0.434 0.02 CID_654 | CID_654 | |
| 0.178 | 0.034 | 0.576 | Aldehyde dehydrogenase inhibitor | 0.131 0.061 CID_135444498 0.576 0.004 CID_654 | CID_654 | |
| 0.172 | 0.047 | 0.412 | Mannose-6-phosphate isomerase inhibitor | 0.115 0.111 CID_135444498 0.412 0.003 CID_654 | CID_654 | |
| 0.166 | 0.048 | 0.674 | Bone formation stimulant | 0.674 0.003 CID_654 | CID_654 | |
| 0.167 | 0.068 | 0.246 | Arachidonic acid antagonist | 0.145 0.095 CID_135444498 0.246 0.006 CID_654 | CID_654 | |
| 0.128 | 0.038 | 0.44 | Adenylate kinase inhibitor | 0.108 0.055 CID_135444498 0.44 0.002 CID_654 | CID_654 | |
| 0.121 | 0.032 | 0.627 | Triose-phosphate isomerase inhibitor | 0.088 0.062 CID_135444498 0.627 0.002 CID_654 | CID_654 | |
| 0.095 | 0.007 | 0.496 | Sphingosine 1-phosphate receptor 3 agonist | 0.496 0.002 CID_654 | CID_654 | |
| 0.127 | 0.039 | 0.532 | UDP-glucose 4-epimerase inhibitor | 0.12 0.044 CID_135444498 0.532 0.002 CID_654 | CID_654 | |
| 0.141 | 0.054 | 0.313 | Sphingosine 1-phosphate receptor 2 antagonist | 0.119 0.099 CID_135444498 0.313 0.003 CID_654 | CID_654 | |
| 0.165 | 0.08 | 0.59 | Phospholipase C inhibitor | 0.59 0.004 CID_654 | CID_654 | |
| 0.136 | 0.057 | 0.563 | DNA polymerase I inhibitor | 0.563 0.003 CID_654 | CID_654 | |
| 0.187 | 0.116 | 0.419 | Vasodilator | 0.419 0.02 CID_654 | CID_654 | |
| 0.105 | 0.039 | 0.525 | NADH dehydrogenase inhibitor | 0.098 0.046 CID_135444498 0.525 0.003 CID_654 | CID_654 | |
| 0.085 | 0.02 | 0.301 | Acyl-CoA dehydrogenase inhibitor | 0.301 0.001 CID_654 | CID_654 | |
| 0.083 | 0.019 | 0.385 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.063 0.031 CID_135444498 0.385 0.002 CID_654 | CID_654 | |
| 0.185 | 0.129 | 0.527 | Immunostimulant | 0.527 0.026 CID_654 | CID_654 | |
| 0.057 | 0.008 | 0.318 | Purinergic P2X agonist | 0.318 0.001 CID_654 | CID_654 | |
| 0.189 | 0.14 | 0.554 | DNA synthesis inhibitor | 0.178 0.157 CID_135444498 0.554 0.01 CID_654 | CID_654 | |
| 0.091 | 0.042 | 0.265 | Carbonic anhydrase XIII inhibitor | 0.265 0.008 CID_654 | CID_654 | |
| 0.056 | 0.009 | 0.21 | Purinergic P2Y2 antagonist | 0.21 0.001 CID_654 | CID_654 | |
| 0.124 | 0.081 | 0.265 | Alkaline phosphatase inhibitor | 0.265 0.017 CID_654 | CID_654 | |
| 0.048 | 0.005 | 0.188 | Growth factor receptor-bound protein 2 antagonist | 0.188 0.002 CID_654 | CID_654 | |
| 0.111 | 0.074 | 0.332 | Cholesterol synthesis inhibitor | 0.332 0.008 CID_654 | CID_654 | |
| 0.091 | 0.057 | 0.273 | Phosphodiesterase I inhibitor | 0.273 0.005 CID_135444498 0.14 0.02 CID_654 | CID_135444498 | |
| 0.115 | 0.081 | 0.377 | Sphingosine 1-phosphate receptor 4 antagonist | 0.377 0.003 CID_654 | CID_654 | |
| 0.076 | 0.044 | 0.415 | Phosphofructokinase-1 inhibitor | 0.415 0.003 CID_654 | CID_654 | |
| 0.12 | 0.088 | 0.203 | Vanilloid 1 agonist | 0.203 0.011 CID_654 | CID_654 | |
| 0.066 | 0.035 | 0.397 | Biliverdin reductase inhibitor | 0.069 0.033 CID_135444498 0.397 0.002 CID_654 | CID_654 | |
| 0.052 | 0.023 | 0.11 | Fructose-1,6-bisphosphatase inhibitor | 0.11 0.004 CID_654 | CID_654 | |
| 0.053 | 0.025 | 0.073 | Cholesterol esterase inhibitor | 0.073 0.009 CID_654 | CID_654 | |
| 0.057 | 0.031 | 0.516 | Sphingosine 1-phosphate receptor 5 agonist | 0.516 0.003 CID_654 | CID_654 | |
| 0.098 | 0.073 | 0.389 | Toll-Like receptor 4 antagonist | 0.389 0.003 CID_654 | CID_654 | |
| 0.075 | 0.051 | 0.6 | Porphobilinogen synthase inhibitor | 0.121 0.028 CID_135444498 0.6 0.003 CID_654 | CID_654 | |
| 0.05 | 0.027 | 0.211 | Purinergic P2Y antagonist | 0.211 0.004 CID_654 | CID_654 | |
| 0.032 | 0.009 | 0.267 | Toll-Like receptor 4 agonist | 0.267 0.001 CID_654 | CID_654 | |
| 0.094 | 0.075 | 0.212 | Glutamate (mGluR7) agonist | 0.092 0.078 CID_135444498 0.212 0.004 CID_654 | CID_654 | |
| 0.143 | 0.124 | 0.3 | Non-steroidal antiinflammatory agent | 0.3 0.028 CID_654 | CID_654 | |
| 0.046 | 0.028 | 0.125 | Geranyltranstransferase inhibitor | 0.125 0.003 CID_654 | CID_654 | |
| 0.048 | 0.032 | 0.23 | Glucose-6-phosphate isomerase inhibitor | 0.23 0.001 CID_654 | CID_654 | |
| 0.04 | 0.026 | 0.04 | Aggrecanase 1 inhibitor | |||
| 0.021 | 0.008 | 0.201 | Purinergic P2Y1 antagonist | 0.201 0.002 CID_654 | CID_654 | |
| 0.014 | 0.003 | 0.107 | Mannitol 2-dehydrogenase inhibitor | 0.107 0 CID_654 | CID_654 | |
| 0.064 | 0.054 | 0.381 | Glutamate (mGluR6) antagonist | 0.381 0.002 CID_654 | CID_654 | |
| 0.062 | 0.053 | 0.274 | Sphingosine 1-phosphate receptor 4 agonist | 0.274 0.003 CID_654 | CID_654 | |
| 0.068 | 0.06 | 0.092 | Phosphodiesterase VIII inhibitor | 0.092 0.02 CID_135444498 | CID_135444498 | |
| 0.123 | 0.116 | 0.283 | Sphingosine 1-phosphate receptor 5 antagonist | 0.283 0.003 CID_654 | CID_654 | |
| 0.057 | 0.052 | 0.095 | Corticotropin releasing factor 2 receptor antagonist | 0.095 0.008 CID_135444498 0.077 0.019 CID_654 | CID_135444498 | |
| 0.014 | 0.011 | 0.155 | Purinergic receptor agonist | 0.155 0.001 CID_654 | CID_654 | |
| 0.014 | 0.011 | 0.155 | Purinergic P2 agonist | 0.155 0.001 CID_654 | CID_654 | |
| 0.083 | 0.08 | 0.346 | DNA directed RNA polymerase inhibitor | 0.107 0.049 CID_135444498 0.346 0.005 CID_654 | CID_654 | |
| 0.01 | 0.011 | 0.136 | Purinergic P2Y agonist | 0.136 0.001 CID_654 | CID_654 | |
| 0.181 | 0.183 | 0.348 | Cholesterol antagonist | 0.259 0.119 CID_135444498 0.348 0.065 CID_654 | CID_654 | |
| 0.017 | 0.019 | 0.035 | Methylmalonyl-CoA mutase inhibitor | 0.035 0.002 CID_654 | CID_654 | |
| 0.051 | 0.054 | 0.437 | Carbamoyl phosphate synthetase inhibitor | 0.437 0.003 CID_654 | CID_654 | |
| 0.148 | 0.155 | 0.354 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.354 0.012 CID_654 | CID_654 | |
| 0.002 | 0.01 | 0.019 | Purinergic P2Y4 agonist | 0.019 0.001 CID_654 | CID_654 | |
| 0.032 | 0.043 | 0.119 | Glutamate (mGluR8) agonist | 0.119 0.002 CID_654 | CID_654 | |
| 0.033 | 0.045 | 0.09 | Vanilloid 3 antagonist | 0.09 0.003 CID_654 | CID_654 | |
| 0.035 | 0.047 | 0.053 | Angiotensin AT1 receptor antagonist | 0.053 0.013 CID_135444498 | CID_135444498 | |
| 0.033 | 0.046 | 0.128 | Sphingosine 1-phosphate receptor 1 agonist | 0.128 0.004 CID_654 | CID_654 | |
| 0.082 | 0.095 | 0.173 | Anabolic | 0.088 0.081 CID_135444498 0.173 0.009 CID_654 | CID_654 | |
| 0.046 | 0.06 | 0.056 | Angiotensin-converting enzyme inhibitor | 0.056 0.036 CID_654 | CID_654 | |
| 0.047 | 0.064 | 0.21 | Sphingosine 1-phosphate receptor 3 antagonist | 0.21 0.003 CID_654 | CID_654 | |
| 0.059 | 0.077 | 0.435 | Glutamate dehydrogenase inhibitor | 0.435 0.004 CID_654 | CID_654 | |
| 0.011 | 0.029 | 0.052 | Purinergic P2Y1 agonist | 0.052 0.002 CID_654 | CID_654 | |
| 0.033 | 0.054 | 0.142 | Sphingosine 1-phosphate receptor agonist | 0.142 0.004 CID_654 | CID_654 | |
| 0.011 | 0.032 | 0.153 | Inosine monophosphate dehydrogenase 1 inhibitor | 0.153 0.002 CID_654 | CID_654 | |
| 0.007 | 0.029 | 0.109 | Lysophosphatidic acid receptor 3 agonist | 0.109 0.001 CID_654 | CID_654 | |
| 0.016 | 0.039 | 0.067 | Toll-Like receptor 8 agonist | 0.067 0.003 CID_654 | CID_654 | |
| 0.018 | 0.042 | 0.105 | Lysophosphatidic acid receptor 1 agonist | 0.105 0.002 CID_654 | CID_654 | |
| 0.025 | 0.051 | 0.04 | Angiotensin II receptor antagonist | 0.04 0.014 CID_135444498 | CID_135444498 | |
| 0.013 | 0.04 | 0.086 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.086 0.004 CID_654 | CID_654 | |
| 0.083 | 0.11 | 0.293 | Folate antagonist | 0.114 0.045 CID_135444498 0.293 0.004 CID_654 | CID_654 | |
| 0.036 | 0.065 | 0.173 | Lysophosphatidic acid 3 receptor antagonist | 0.173 0.002 CID_654 | CID_654 | |
| 0.097 | 0.128 | 0.274 | Protein kinase stimulant | 0.274 0.021 CID_654 | CID_654 | |
| 0.046 | 0.077 | 0.185 | Purinergic P2X1 antagonist | 0.185 0.004 CID_654 | CID_654 | |
| 0.06 | 0.092 | 0.261 | Keratolytic | 0.261 0.005 CID_654 | CID_654 | |
| 0.08 | 0.116 | 0.303 | GABA C receptor antagonist | 0.15 0.03 CID_135444498 0.303 0.004 CID_654 | CID_654 | |
| 0 | 0.041 | 0.003 | Purinergic P2Y6 agonist | 0.003 0.002 CID_654 | CID_654 | |
| 0.033 | 0.077 | 0.056 | Alpha 1L adrenoreceptor agonist | 0.056 0.011 CID_135444498 | CID_135444498 | |
| 0.028 | 0.073 | 0.094 | Thymidine kinase inhibitor | 0.039 0.032 CID_135444498 0.094 0.007 CID_654 | CID_654 | |
| 0.018 | 0.063 | 0.028 | Phosphodiesterase 6B inhibitor | 0.028 0.026 CID_135444498 | CID_135444498 | |
| 0.01 | 0.057 | 0.098 | Purinergic P2Y12 antagonist | 0.098 0.004 CID_654 | CID_654 | |
| 0.006 | 0.054 | 0.015 | Purinergic P2Y2 agonist | 0.015 0.003 CID_654 | CID_654 | |
| 0.182 | 0.233 | 0.475 | GABA C receptor rho-3 antagonist | 0.475 0.033 CID_135444498 0.401 0.061 CID_654 | CID_135444498 | |
| 0.041 | 0.093 | 0.132 | HIV-1 reverse transcriptase inhibitor | 0.132 0.018 CID_135444498 0.117 0.023 CID_654 | CID_135444498 | |
| 0.006 | 0.058 | 0.019 | Purine nucleoside phosphorylase inhibitor | 0.019 0.004 CID_654 | CID_654 | |
| 0.037 | 0.09 | 0.279 | Purinergic P2 antagonist | 0.279 0.005 CID_654 | CID_654 | |
| 0.059 | 0.118 | 0.202 | Sphingosine 1-phosphate receptor antagonist | 0.202 0.004 CID_654 | CID_654 | |
| 0.015 | 0.074 | 0.035 | Vanilloid 2 agonist | 0.035 0.005 CID_654 | CID_654 | |
| 0.054 | 0.113 | 0.076 | Phosphodiesterase VI inhibitor | 0.071 0.058 CID_135444498 0.076 0.048 CID_654 | CID_654 | |
| 0.011 | 0.071 | 0.059 | Lysophosphatidic acid 1 receptor antagonist | 0.059 0.003 CID_654 | CID_654 | |
| 0.016 | 0.077 | 0.245 | Fumarate hydratase inhibitor | 0.245 0.003 CID_654 | CID_654 | |
| 0.013 | 0.076 | 0.049 | Retinoid X receptor agonist | 0.049 0.018 CID_654 | CID_654 | |
| 0.072 | 0.137 | 0.275 | Alkylator | 0.275 0.014 CID_654 | CID_654 | |
| 0.028 | 0.094 | 0.247 | Phosphodiesterase 2A inhibitor | 0.247 0.004 CID_135444498 | CID_135444498 | |
| 0.029 | 0.096 | 0.296 | Argininosuccinate synthase inhibitor | 0.056 0.04 CID_135444498 0.296 0.004 CID_654 | CID_654 | |
| 0.031 | 0.098 | 0.259 | Phosphodiesterase II inhibitor | 0.259 0.004 CID_135444498 | CID_135444498 | |
| 0.035 | 0.103 | 0.045 | Phosphodiesterase 6C inhibitor | 0.045 0.038 CID_135444498 | CID_135444498 | |
| 0.023 | 0.094 | 0.048 | Leukocyte elastase inhibitor | 0.048 0.025 CID_654 | CID_654 | |
| 0.023 | 0.093 | 0.252 | Ornithine carbamoyltransferase inhibitor | 0.252 0.005 CID_654 | CID_654 | |
| 0.016 | 0.087 | 0.317 | Lysophosphatidic acid 2 receptor antagonist | 0.317 0.002 CID_654 | CID_654 | |
| 0.021 | 0.094 | 0.174 | Antimetabolite | 0.174 0.011 CID_654 | CID_654 | |
| 0.042 | 0.117 | 0.165 | Phosphodiesterase 1A inhibitor | 0.165 0.004 CID_135444498 | CID_135444498 | |
| 0.003 | 0.078 | 0.044 | Glutamate (mGluR6) agonist | 0.044 0.002 CID_654 | CID_654 | |
| 0.009 | 0.086 | 0.077 | Uridine phosphorylase inhibitor | 0.077 0.004 CID_654 | CID_654 | |
| 0.037 | 0.115 | 0.122 | Phosphodiesterase 1B inhibitor | 0.122 0.01 CID_135444498 | CID_135444498 | |
| 0.02 | 0.1 | 0.08 | Guanylate cyclase inhibitor | 0.08 0.003 CID_654 | CID_654 | |
| 0.075 | 0.155 | 0.209 | Cyclooxygenase 3 inhibitor | 0.209 0.016 CID_654 | CID_654 | |
| 0.021 | 0.103 | 0.091 | Thymidylate synthase inhibitor | 0.055 0.021 CID_135444498 0.091 0.005 CID_654 | CID_654 | |
| 0.013 | 0.097 | 0.147 | Phosphoglycerate kinase inhibitor | 0.147 0.004 CID_654 | CID_654 | |
| 0.055 | 0.14 | 0.209 | Glutathione S-transferase inhibitor | 0.209 0.005 CID_654 | CID_654 | |
| 0.006 | 0.09 | 0.103 | Purinergic P2T antagonist | 0.103 0.005 CID_654 | CID_654 | |
| 0.035 | 0.122 | 0.062 | Cannabinoid receptor antagonist | 0.062 0.059 CID_135444498 | CID_135444498 | |
| 0.058 | 0.147 | 0.436 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.1 0.054 CID_135444498 0.436 0.003 CID_654 | CID_654 | |
| 0.058 | 0.15 | 0.351 | Ferrochelatase inhibitor | 0.351 0.005 CID_135444498 0.133 0.046 CID_654 | CID_135444498 | |
| 0.128 | 0.221 | 0.201 | Hypoglycemic | 0.201 0.112 CID_135444498 | CID_135444498 | |
| 0.045 | 0.139 | 0.088 | Phosphodiesterase 3A inhibitor | 0.088 0.044 CID_135444498 | CID_135444498 | |
| 0.117 | 0.212 | 0.198 | Heat shock protein 70 antagonist | 0.129 0.125 CID_135444498 0.198 0.007 CID_654 | CID_654 | |
| 0.062 | 0.16 | 0.114 | Vanilloid agonist | 0.114 0.022 CID_654 | CID_654 | |
| 0.147 | 0.245 | 0.341 | Vasodilator, coronary | 0.341 0.06 CID_654 | CID_654 | |
| 0.068 | 0.166 | 0.115 | Phosphodiesterase 6D inhibitor | 0.115 0.03 CID_654 | CID_654 | |
| 0.008 | 0.115 | 0.049 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.049 0.004 CID_654 | CID_654 | |
| 0.019 | 0.129 | 0.054 | Glutamate (mGluR4) agonist | 0.054 0.01 CID_654 | CID_654 | |
| 0.041 | 0.151 | 0.067 | Lipocortins synthesis agonist | 0.067 0.024 CID_654 | CID_654 | |
| 0.068 | 0.178 | 0.204 | DOPA decarboxylase inhibitor | 0.204 0.006 CID_654 | CID_654 | |
| 0.085 | 0.197 | 0.372 | Hexokinase inhibitor | 0.372 0.005 CID_654 | CID_654 | |
| 0.115 | 0.228 | 0.163 | Ca2+-transporting ATPase inhibitor | 0.136 0.091 CID_135444498 0.163 0.02 CID_654 | CID_654 | |
| 0.018 | 0.131 | 0.067 | Membrane dipeptidase inhibitor | 0.067 0.008 CID_654 | CID_654 | |
| 0.027 | 0.143 | 0.06 | Cytokine production stimulant | 0.06 0.013 CID_654 | CID_654 | |
| 0.115 | 0.233 | 0.249 | Cyclic AMP phosphodiesterase inhibitor | 0.249 0.064 CID_135444498 0.228 0.076 CID_654 | CID_135444498 | |
| 0.04 | 0.16 | 0.153 | Ornithine decarboxylase inhibitor | 0.153 0.01 CID_654 | CID_654 | |
| 0.155 | 0.275 | 0.436 | Histamine release inhibitor | 0.436 0.057 CID_135444498 0.317 0.115 CID_654 | CID_135444498 | |
| 0.033 | 0.154 | 0.15 | Sphingosine 1-phosphate receptor 1 antagonist | 0.15 0.004 CID_654 | CID_654 | |
| 0.082 | 0.204 | 0.454 | Pyruvate kinase inhibitor | 0.454 0.013 CID_654 | CID_654 | |
| 0.049 | 0.174 | 0.437 | Aminoacyl-tRNA synthetase inhibitor | 0.437 0.004 CID_654 | CID_654 | |
| 0.047 | 0.173 | 0.292 | Sphingomyelinase inhibitor | 0.292 0.004 CID_654 | CID_654 | |
| 0.026 | 0.156 | 0.148 | Glutamate (mGluR group III) antagonist | 0.148 0.004 CID_654 | CID_654 | |
| 0.012 | 0.143 | 0.119 | Ribonucleotide reductase inhibitor | 0.119 0.017 CID_654 | CID_654 | |
| 0.033 | 0.164 | 0.183 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.183 0.012 CID_654 | CID_654 | |
| 0.021 | 0.152 | 0.069 | AICAR transformylase inhibitor | 0.041 0.037 CID_135444498 0.069 0.01 CID_654 | CID_654 | |
| 0.014 | 0.146 | 0.038 | Thymidine phosphorylase inhibitor | 0.027 0.017 CID_135444498 0.038 0.007 CID_654 | CID_654 | |
| 0.013 | 0.146 | 0.111 | Ribonucleoside-diphosphate reductase inhibitor | 0.111 0.017 CID_654 | CID_654 | |
| 0.088 | 0.222 | 0.24 | Adenylate cyclase stimulant | 0.24 0.005 CID_654 | CID_654 | |
| 0.03 | 0.165 | 0.104 | Antiviral (Hepatitis D) | 0.104 0.004 CID_654 | CID_654 | |
| 0.03 | 0.168 | 0.091 | Na+ K+ transporting ATPase inhibitor | 0.091 0.04 CID_654 | CID_654 | |
| 0.009 | 0.147 | 0.032 | Free fatty acid receptor 1 antagonist | 0.032 0.027 CID_135444498 | CID_135444498 | |
| 0.142 | 0.282 | 0.282 | DNA directed DNA polymerase inhibitor | 0.282 0.172 CID_654 | CID_654 | |
| 0.028 | 0.168 | 0.077 | Bombesin 3 receptor antagonist | 0.077 0.02 CID_135444498 | CID_135444498 | |
| 0.06 | 0.2 | 0.362 | Alpha-N-acetylglucosaminidase inhibitor | 0.149 0.056 CID_135444498 0.362 0.011 CID_654 | CID_654 | |
| 0.016 | 0.157 | 0.032 | Glucosylceramidase stimulant | 0.032 0.009 CID_135444498 | CID_135444498 | |
| 0.064 | 0.209 | 0.371 | Toll-Like receptor 2 antagonist | 0.371 0.003 CID_654 | CID_654 | |
| 0.012 | 0.159 | 0.108 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.108 0.004 CID_654 | CID_654 | |
| 0.011 | 0.158 | 0.024 | Thyroid hormone agonist | 0.024 0.022 CID_135444498 | CID_135444498 | |
| 0.005 | 0.153 | 0.131 | Squalene synthetase inhibitor | 0.131 0.004 CID_654 | CID_654 | |
| 0.02 | 0.171 | 0.084 | Glutamate (mGluR group III) agonist | 0.084 0.012 CID_654 | CID_654 | |
| 0.054 | 0.205 | 0.213 | Mucolytic | 0.213 0.011 CID_654 | CID_654 | |
| 0.053 | 0.206 | 0.1 | Granulocyte macrophage colony stimulating factor agonist | 0.081 0.074 CID_135444498 0.1 0.035 CID_654 | CID_654 | |
| 0.037 | 0.194 | 0.122 | Phosphodiesterase 1C inhibitor | 0.122 0.006 CID_135444498 | CID_135444498 | |
| 0.036 | 0.197 | 0.117 | Interferon agonist | 0.117 0.018 CID_654 | CID_654 | |
| 0.03 | 0.196 | 0.083 | Calcium antagonist | 0.083 0.061 CID_654 | CID_654 | |
| 0.024 | 0.192 | 0.357 | Histidine decarboxylase inhibitor | 0.357 0.005 CID_654 | CID_654 | |
| 0.028 | 0.198 | 0.085 | Dihydroorotate oxidase inhibitor | 0.085 0.008 CID_135444498 | CID_135444498 | |
| 0.015 | 0.186 | 0.067 | Histamine H2 receptor agonist | 0.067 0.011 CID_135444498 | CID_135444498 | |
| 0.077 | 0.254 | 0.367 | Interleukin agonist | 0.21 0.111 CID_135444498 0.367 0.025 CID_654 | CID_654 | |
| 0.049 | 0.227 | 0.268 | Adenylate cyclase inhibitor | 0.268 0.017 CID_654 | CID_654 | |
| 0.033 | 0.214 | 0.103 | HIV-1 integrase inhibitor | 0.103 0.023 CID_654 | CID_654 | |
| 0.037 | 0.224 | 0.24 | Expectorant | 0.24 0.014 CID_654 | CID_654 | |
| 0.004 | 0.194 | 0.031 | Adenosine kinase inhibitor | 0.031 0.009 CID_654 | CID_654 | |
| 0.009 | 0.2 | 0.055 | Nicotinic acid receptor agonist | 0.055 0.013 CID_135444498 0.035 0.027 CID_654 | CID_135444498 | |
| 0.003 | 0.196 | 0.015 | Carbonic anhydrase X inhibitor | 0.015 0.013 CID_654 | CID_654 | |
| 0.003 | 0.196 | 0.015 | Carbonic anhydrase VIII inhibitor | 0.015 0.013 CID_654 | CID_654 | |
| 0.053 | 0.247 | 0.081 | Estrogen-related receptor beta agonist | 0.08 0.068 CID_135444498 0.081 0.063 CID_654 | CID_654 | |
| 0.01 | 0.205 | 0.12 | Carbonic anhydrase VB inhibitor | 0.12 0.012 CID_654 | CID_654 | |
| 0.073 | 0.269 | 0.211 | Platelet adhesion inhibitor | 0.211 0.066 CID_654 | CID_654 | |
| 0.019 | 0.218 | 0.105 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.105 0.015 CID_654 | CID_654 | |
| 0.057 | 0.256 | 0.105 | TRPA1 agonist | 0.105 0.08 CID_135444498 | CID_135444498 | |
| 0.028 | 0.23 | 0.1 | CDC25A inhibitor | 0.1 0.028 CID_654 | CID_654 | |
| 0.014 | 0.216 | 0.064 | Adenosine deaminase inhibitor | 0.064 0.017 CID_654 | CID_654 | |
| 0.006 | 0.209 | 0.097 | Bombesin 3 receptor agonist | 0.097 0.004 CID_135444498 | CID_135444498 | |
| 0.019 | 0.226 | 0.06 | Aconitate hydratase inhibitor | 0.06 0.026 CID_654 | CID_654 | |
| 0.014 | 0.227 | 0.031 | Glutamate (mGluR3) agonist | 0.031 0.027 CID_654 | CID_654 | |
| 0.001 | 0.214 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.005 CID_135444498 | CID_135444498 | |
| 0.015 | 0.228 | 0.12 | Alcohol oxidase inhibitor | 0.12 0.014 CID_654 | CID_654 | |
| 0.049 | 0.264 | 0.14 | D-Ala-D-Ala ligase inhibitor | 0.14 0.007 CID_654 | CID_654 | |
| 0.025 | 0.239 | 0.125 | Aminopeptidase I inhibitor | 0.125 0.018 CID_654 | CID_654 | |
| 0.082 | 0.297 | 0.222 | Succinate dehydrogenase inhibitor | 0.144 0.123 CID_135444498 0.222 0.034 CID_654 | CID_654 | |
| 0.009 | 0.225 | 0.056 | Cannabinoid CB2 receptor antagonist | 0.056 0.033 CID_135444498 | CID_135444498 | |
| 0.006 | 0.222 | 0.117 | Bombesin agonist | 0.117 0.004 CID_135444498 | CID_135444498 | |
| 0.071 | 0.287 | 0.179 | GABA C receptor rho-2 antagonist | 0.179 0.043 CID_135444498 0.156 0.065 CID_654 | CID_135444498 | |
| 0.028 | 0.244 | 0.183 | Potassium channel (Ca-activated) activator | 0.183 0.018 CID_654 | CID_654 | |
| 0.019 | 0.238 | 0.07 | Androgen agonist | 0.07 0.03 CID_654 | CID_654 | |
| 0.101 | 0.32 | 0.487 | Transcription factor STAT3 inhibitor | 0.487 0.008 CID_654 | CID_654 | |
| 0.02 | 0.24 | 0.062 | Phenylalanine 4-hydroxylase inhibitor | 0.062 0.055 CID_135444498 0.062 0.056 CID_654 | CID_654 | |
| 0.004 | 0.226 | 0.059 | Inosine monophosphate dehydrogenase 2 inhibitor | 0.059 0.004 CID_654 | CID_654 | |
| 0.015 | 0.239 | 0.048 | Histamine H1 receptor agonist | 0.048 0.022 CID_135444498 | CID_135444498 | |
| 0.071 | 0.297 | 0.178 | DNA repair enzyme inhibitor | 0.126 0.061 CID_135444498 0.178 0.014 CID_654 | CID_654 | |
| 0.052 | 0.28 | 0.301 | Toll-Like receptor antagonist | 0.301 0.007 CID_654 | CID_654 | |
| 0.041 | 0.271 | 0.203 | GABA C receptor rho-1 antagonist | 0.101 0.06 CID_135444498 0.203 0.008 CID_654 | CID_654 | |
| 0.019 | 0.25 | 0.066 | Purinergic P2X4 antagonist | 0.066 0.011 CID_654 | CID_654 | |
| 0.007 | 0.242 | 0.048 | Geranylgeranyltransferase inhibitor | 0.048 0.005 CID_654 | CID_654 | |
| 0.002 | 0.24 | 0.042 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | 0.042 0.004 CID_654 | CID_654 | |
| 0.075 | 0.314 | 0.129 | Pregnane X receptor agonist | 0.129 0.102 CID_135444498 | CID_135444498 | |
| 0.066 | 0.306 | 0.26 | Platelet antagonist | 0.26 0.068 CID_654 | CID_654 | |
| 0.009 | 0.253 | 0.055 | Phosphodiesterase 9A inhibitor | 0.055 0.004 CID_135444498 | CID_135444498 | |
| 0.027 | 0.272 | 0.132 | Glycine receptor antagonist | 0.132 0.012 CID_654 | CID_654 | |
| 0.077 | 0.324 | 0.191 | Neurotrophic factor enhancer | 0.191 0.086 CID_654 | CID_654 | |
| 0.032 | 0.286 | 0.066 | Glycine receptor agonist | 0.066 0.064 CID_135444498 | CID_135444498 | |
| 0.047 | 0.302 | 0.124 | Antibacterial (Helicobacter pylori) | 0.124 0.076 CID_135444498 | CID_135444498 | |
| 0.004 | 0.261 | 0.04 | Carbonic anhydrase IV inhibitor | 0.04 0.032 CID_654 | CID_654 | |
| 0.059 | 0.316 | 0.2 | Transcription factor STAT6 inhibitor | 0.2 0.007 CID_654 | CID_654 | |
| 0.117 | 0.375 | 0.263 | Tyrosine 3 hydroxylase inhibitor | 0.217 0.108 CID_135444498 0.263 0.057 CID_654 | CID_654 | |
| 0.03 | 0.288 | 0.068 | Orexin receptor 1 antagonist | 0.068 0.06 CID_135444498 | CID_135444498 | |
| 0.019 | 0.278 | 0.087 | Sphingosine kinase 2 inhibitor | 0.087 0.012 CID_654 | CID_654 | |
| 0.008 | 0.269 | 0.116 | Inosine monophosphate dehydrogenase inhibitor | 0.116 0.004 CID_654 | CID_654 | |
| 0.051 | 0.315 | 0.097 | CC chemokine 5 receptor agonist | 0.097 0.025 CID_135444498 | CID_135444498 | |
| 0.04 | 0.304 | 0.215 | Beta amyloid protein antagonist | 0.215 0.013 CID_654 | CID_654 | |
| 0.043 | 0.307 | 0.137 | Microtubule formation inhibitor | 0.137 0.045 CID_654 | CID_654 | |
| 0.095 | 0.359 | 0.469 | Antithrombotic | 0.469 0.034 CID_654 | CID_654 | |
| 0.006 | 0.272 | 0.037 | Nicotinic acid receptor 2 antagonist | 0.037 0.006 CID_135444498 | CID_135444498 | |
| 0.149 | 0.416 | 0.571 | Caspase 9 stimulant | 0.571 0.041 CID_654 | CID_654 | |
| 0.007 | 0.276 | 0.025 | 5 Hydroxytryptamine 4 agonist | 0.025 0.015 CID_135444498 | CID_135444498 | |
| 0.012 | 0.283 | 0.027 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.027 0.017 CID_654 | CID_654 | |
| 0.036 | 0.309 | 0.085 | GABA B receptor agonist | 0.074 0.057 CID_135444498 0.085 0.033 CID_654 | CID_654 | |
| 0.087 | 0.361 | 0.513 | Transcription factor STAT inhibitor | 0.513 0.007 CID_654 | CID_654 | |
| 0.096 | 0.371 | 0.322 | Vasodilator, peripheral | 0.271 0.113 CID_135444498 0.322 0.086 CID_654 | CID_654 | |
| 0.028 | 0.305 | 0.164 | Aminopeptidase B inhibitor | 0.164 0.032 CID_654 | CID_654 | |
| 0.003 | 0.281 | 0.023 | Neutral endopeptidase inhibitor | 0.023 0.014 CID_654 | CID_654 | |
| 0.016 | 0.294 | 0.058 | GABA B receptor antagonist | 0.058 0.014 CID_654 | CID_654 | |
| 0.043 | 0.322 | 0.136 | Transcription factor NF kappa B stimulant | 0.136 0.019 CID_654 | CID_654 | |
| 0.064 | 0.343 | 0.176 | Melanin inhibitor | 0.176 0.054 CID_654 | CID_654 | |
| 0.02 | 0.3 | 0.055 | Heparanase inhibitor | 0.055 0.033 CID_654 | CID_654 | |
| 0.009 | 0.291 | 0.08 | Adenosine A1 receptor antagonist | 0.08 0.028 CID_135444498 | CID_135444498 | |
| 0.014 | 0.296 | 0.162 | Carbonic anhydrase V inhibitor | 0.162 0.012 CID_654 | CID_654 | |
| 0.011 | 0.296 | 0.049 | Dihydroorotate dehydrogenase inhibitor | 0.049 0.038 CID_135444498 | CID_135444498 | |
| 0.069 | 0.355 | 0.254 | DNA damaging | 0.254 0.078 CID_135444498 0.213 0.105 CID_654 | CID_135444498 | |
| 0.02 | 0.307 | 0.369 | Autotaxin inhibitor | 0.369 0.004 CID_654 | CID_654 | |
| 0.043 | 0.331 | 0.107 | mTOR complex 1 inhibitor | 0.107 0.049 CID_135444498 | CID_135444498 | |
| 0.01 | 0.298 | 0.082 | HIV-1 integrase (Strand Transfer) inhibitor | 0.082 0.03 CID_654 | CID_654 | |
| 0.029 | 0.319 | 0.129 | Tubulin antagonist | 0.129 0.072 CID_654 | CID_654 | |
| 0.028 | 0.319 | 0.093 | Adenine nucleotide translocase inhibitor | 0.093 0.005 CID_654 | CID_654 | |
| 0.034 | 0.324 | 0.443 | Phosphodiesterase inhibitor | 0.443 0.005 CID_135444498 | CID_135444498 | |
| 0.03 | 0.321 | 0.132 | GABA C receptor agonist | 0.13 0.043 CID_135444498 0.132 0.042 CID_654 | CID_654 | |
| 0.004 | 0.296 | 0.023 | Imidazoline I1 receptor antagonist | 0.023 0.011 CID_135444498 | CID_135444498 | |
| 0.01 | 0.303 | 0.077 | Phosphodiesterase VII inhibitor | 0.077 0.029 CID_135444498 | CID_135444498 | |
| 0.138 | 0.433 | 0.416 | Calcium channel L-type activator | 0.416 0.071 CID_135444498 | CID_135444498 | |
| 0.002 | 0.297 | 0.014 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.014 0.008 CID_654 | CID_654 | |
| 0.106 | 0.403 | 0.232 | Nitric-oxide synthase stimulant | 0.232 0.047 CID_135444498 0.2 0.089 CID_654 | CID_135444498 | |
| 0.025 | 0.325 | 0.078 | Transforming growth factor antagonist | 0.078 0.038 CID_135444498 | CID_135444498 | |
| 0.031 | 0.332 | 0.308 | Chelator | 0.308 0.01 CID_654 | CID_654 | |
| 0.022 | 0.324 | 0.225 | Alcohol dehydrogenase inhibitor | 0.225 0.01 CID_654 | CID_654 | |
| 0.02 | 0.325 | 0.202 | Potassium channel (Ca-activated) blocker | 0.202 0.005 CID_654 | CID_654 | |
| 0.014 | 0.318 | 0.093 | Catalase inhibitor | 0.093 0.041 CID_654 | CID_654 | |
| 0.088 | 0.398 | 0.646 | Immunomodulator | 0.646 0.008 CID_654 | CID_654 | |
| 0.116 | 0.429 | 0.186 | 5 Hydroxytryptamine 3E antagonist | 0.168 0.142 CID_135444498 0.186 0.089 CID_654 | CID_654 | |
| 0.02 | 0.335 | 0.088 | Potassium channel intermediate-conductance Ca-activated blocker | 0.088 0.013 CID_654 | CID_654 | |
| 0.132 | 0.448 | 0.359 | 5 Hydroxytryptamine release inhibitor | 0.359 0.108 CID_135444498 0.294 0.172 CID_654 | CID_135444498 | |
| 0.032 | 0.348 | 0.449 | Psychostimulant | 0.449 0.016 CID_654 | CID_654 | |
| 0.018 | 0.342 | 0.09 | Phospholipase D inhibitor | 0.09 0.022 CID_654 | CID_654 | |
| 0.011 | 0.337 | 0.068 | Histamine agonist | 0.068 0.021 CID_135444498 | CID_135444498 | |
| 0.008 | 0.338 | 0.042 | Toll-Like receptor 2 agonist | 0.042 0.028 CID_654 | CID_654 | |
| 0.007 | 0.338 | 0.055 | Phosphodiesterase IX inhibitor | 0.055 0.004 CID_135444498 | CID_135444498 | |
| 0.01 | 0.342 | 0.085 | HIV-1 integrase (3'-Processing) inhibitor | 0.085 0.032 CID_654 | CID_654 | |
| 0.044 | 0.38 | 0.152 | Hematopoietic | 0.152 0.015 CID_654 | CID_654 | |
| 0.036 | 0.374 | 0.117 | Lanosterol 14 alpha demethylase inhibitor | 0.117 0.033 CID_654 | CID_654 | |
| 0.012 | 0.351 | 0.061 | Alpha-mannosidase inhibitor | 0.061 0.026 CID_654 | CID_654 | |
| 0.014 | 0.357 | 0.113 | Glutamate decarboxylase inhibitor | 0.113 0.023 CID_654 | CID_654 | |
| 0.037 | 0.382 | 0.271 | Angiogenesis stimulant | 0.271 0.061 CID_654 | CID_654 | |
| 0.004 | 0.349 | 0.029 | CXC chemokine 2 receptor antagonist | 0.029 0.015 CID_135444498 | CID_135444498 | |
| 0.039 | 0.385 | 0.105 | Photosensitizer | 0.105 0.079 CID_135444498 | CID_135444498 | |
| 0.025 | 0.372 | 0.055 | Cathepsin E inhibitor | 0.055 0.048 CID_654 | CID_654 | |
| 0.008 | 0.363 | 0.046 | Mannosidase inhibitor | 0.046 0.031 CID_654 | CID_654 | |
| 0.023 | 0.378 | 0.178 | Creatine kinase inhibitor | 0.178 0.015 CID_654 | CID_654 | |
| 0.005 | 0.363 | 0.059 | Cannabinoid CB1 receptor agonist | 0.059 0.044 CID_135444498 | CID_135444498 | |
| 0.029 | 0.389 | 0.207 | Cytidine deaminase inhibitor | 0.207 0.044 CID_654 | CID_654 | |
| 0.005 | 0.368 | 0.026 | Urotensin II agonist | 0.026 0.019 CID_654 | CID_654 | |
| 0.014 | 0.382 | 0.179 | c-Src kinase inhibitor | 0.179 0.042 CID_654 | CID_654 | |
| 0.013 | 0.382 | 0.087 | Carbonic anhydrase VA inhibitor | 0.087 0.032 CID_654 | CID_654 | |
| 0.019 | 0.391 | 0.09 | Potassium channel (Voltage-sensitive) activator | 0.09 0.068 CID_135444498 | CID_135444498 | |
| 0.005 | 0.381 | 0.088 | Phosphorylase inhibitor | 0.088 0.015 CID_654 | CID_654 | |
| 0.006 | 0.385 | 0.043 | GABA uptake inhibitor | 0.043 0.022 CID_654 | CID_654 | |
| 0.016 | 0.396 | 0.041 | Glutamate (mGluR4) antagonist | 0.041 0.035 CID_654 | CID_654 | |
| 0.056 | 0.438 | 0.155 | ATPase inhibitor | 0.155 0.094 CID_135444498 | CID_135444498 | |
| 0.006 | 0.388 | 0.044 | Glutamate (mGluR5) antagonist | 0.044 0.036 CID_135444498 | CID_135444498 | |
| 0.037 | 0.42 | 0.152 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | 0.152 0.14 CID_135444498 | CID_135444498 | |
| 0.009 | 0.394 | 0.057 | Cyclin-dependent kinase 6 inhibitor | 0.057 0.045 CID_135444498 | CID_135444498 | |
| 0.141 | 0.527 | 0.412 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.412 0.091 CID_135444498 0.303 0.209 CID_654 | CID_135444498 | |
| 0.006 | 0.4 | 0.053 | Phosphodiesterase 4A inhibitor | 0.053 0.033 CID_135444498 | CID_135444498 | |
| 0.022 | 0.421 | 0.082 | Prolactin inhibitor | 0.082 0.077 CID_135444498 | CID_135444498 | |
| 0.012 | 0.415 | 0.075 | Phosphodiesterase III inhibitor | 0.075 0.04 CID_135444498 | CID_135444498 | |
| 0.023 | 0.427 | 0.094 | MAP kinase kinase 1 inhibitor | 0.094 0.064 CID_135444498 | CID_135444498 | |
| 0.008 | 0.412 | 0.039 | Sphingosine kinase 1 inhibitor | 0.039 0.033 CID_654 | CID_654 | |
| 0.022 | 0.429 | 0.143 | Potassium channel large-conductance Ca-activated activator | 0.143 0.012 CID_654 | CID_654 | |
| 0.075 | 0.483 | 0.26 | Sodium/bile acid cotransporter inhibitor | 0.26 0.118 CID_135444498 | CID_135444498 | |
| 0.024 | 0.432 | 0.28 | Aryl hydrocarbon receptor agonist | 0.28 0.067 CID_135444498 | CID_135444498 | |
| 0.083 | 0.491 | 0.251 | Apoptosis antagonist | 0.251 0.127 CID_654 | CID_654 | |
| 0.039 | 0.448 | 0.249 | Aldehyde oxidase inhibitor | 0.249 0.083 CID_654 | CID_654 | |
| 0.009 | 0.424 | 0.034 | Ceramide glucosyltransferase inhibitor | 0.034 0.027 CID_654 | CID_654 | |
| 0.088 | 0.509 | 0.549 | Apoptosis agonist | 0.549 0.06 CID_654 | CID_654 | |
| 0.024 | 0.454 | 0.123 | Breast cancer-resistant protein inhibitor | 0.123 0.038 CID_654 | CID_654 | |
| 0.004 | 0.439 | 0.05 | Carnitine palmitoyltransferase 1 inhibitor | 0.05 0.008 CID_654 | CID_654 | |
| 0.034 | 0.47 | 0.197 | Platelet aggregation inhibitor | 0.197 0.083 CID_654 | CID_654 | |
| 0.003 | 0.441 | 0.044 | HCV NS5B polymerase inhibitor | 0.044 0.012 CID_654 | CID_654 | |
| 0.034 | 0.475 | 0.131 | Peroxidase inhibitor | 0.131 0.09 CID_654 | CID_654 | |
| 0.028 | 0.469 | 0.084 | mTOR complex 2 inhibitor | 0.084 0.059 CID_135444498 | CID_135444498 | |
| 0.029 | 0.472 | 0.2 | Cell wall synthesis inhibitor | 0.2 0.03 CID_654 | CID_654 | |
| 0.03 | 0.474 | 0.345 | Amyloid beta aggregation inhibitor | 0.345 0.036 CID_654 | CID_654 | |
| 0.053 | 0.498 | 0.18 | Superoxide dismutase inhibitor | 0.18 0.141 CID_654 | CID_654 | |
| 0.004 | 0.449 | 0.05 | Carnitine palmitoyltransferase inhibitor | 0.05 0.008 CID_654 | CID_654 | |
| 0.06 | 0.506 | 0.135 | Lipocortins synthesis antagonist | 0.135 0.13 CID_135444498 | CID_135444498 | |
| 0.059 | 0.507 | 0.301 | Gastrin inhibitor | 0.301 0.032 CID_135444498 | CID_135444498 | |
| 0.005 | 0.455 | 0.07 | Phosphodiesterase 4D inhibitor | 0.07 0.055 CID_135444498 | CID_135444498 | |
| 0.02 | 0.474 | 0.121 | 5 Hydroxytryptamine 3A agonist | 0.121 0.055 CID_135444498 | CID_135444498 | |
| 0.035 | 0.493 | 0.151 | Hemostatic | 0.151 0.067 CID_135444498 0.119 0.117 CID_654 | CID_135444498 | |
| 0.035 | 0.498 | 0.287 | DNA methylase inhibitor | 0.287 0.032 CID_654 | CID_654 | |
| 0.032 | 0.498 | 0.363 | Antiamyloidogenic | 0.363 0.036 CID_654 | CID_654 | |
| 0.066 | 0.533 | 0.217 | 5 Hydroxytryptamine release stimulant | 0.217 0.108 CID_654 | CID_654 | |
| 0.009 | 0.476 | 0.057 | Sphingosine kinase inhibitor | 0.057 0.045 CID_654 | CID_654 | |
| 0.029 | 0.505 | 0.18 | Calpain inhibitor | 0.18 0.134 CID_135444498 | CID_135444498 | |
| 0.012 | 0.49 | 0.093 | Glutamate (mGluR) antagonist | 0.093 0.039 CID_135444498 | CID_135444498 | |
| 0.005 | 0.488 | 0.046 | RNA-directed RNA polymerase inhibitor | 0.046 0.014 CID_654 | CID_654 | |
| 0.019 | 0.511 | 0.131 | Nav1.6 sodium channel blocker | 0.131 0.079 CID_135444498 | CID_135444498 | |
| 0.009 | 0.523 | 0.109 | Phosphodiesterase 5A inhibitor | 0.109 0.023 CID_135444498 | CID_135444498 | |
| 0.037 | 0.556 | 0.234 | Transcription factor NF kappa B inhibitor | 0.234 0.139 CID_654 | CID_654 | |
| 0.005 | 0.524 | 0.02 | Geranylgeranyltransferase I inhibitor | 0.02 0.016 CID_654 | CID_654 | |
| 0.014 | 0.534 | 0.121 | Mediator release inhibitor | 0.121 0.047 CID_135444498 | CID_135444498 | |
| 0.022 | 0.543 | 0.215 | Spasmolytic | 0.215 0.108 CID_654 | CID_654 | |
| 0.005 | 0.527 | 0.057 | NMDA receptor glycine site agonist | 0.057 0.049 CID_654 | CID_654 | |
| 0.008 | 0.537 | 0.108 | Phosphodiesterase V inhibitor | 0.108 0.024 CID_135444498 | CID_135444498 | |
| 0.084 | 0.631 | 0.2 | 5 Hydroxytryptamine uptake stimulant | 0.188 0.178 CID_135444498 0.2 0.151 CID_654 | CID_654 | |
| 0.014 | 0.565 | 0.129 | Neurotrophic factor | 0.129 0.081 CID_654 | CID_654 | |
| 0.007 | 0.566 | 0.065 | CDC7 inhibitor | 0.065 0.05 CID_135444498 | CID_135444498 | |
| 0.007 | 0.57 | 0.158 | Inducible nitric-oxide synthase inhibitor | 0.158 0.014 CID_135444498 | CID_135444498 | |
| 0.005 | 0.572 | 0.088 | Phosphodiesterase IV inhibitor | 0.088 0.055 CID_135444498 | CID_135444498 | |
| 0.006 | 0.575 | 0.068 | Endothelin-converting enzyme inhibitor | 0.068 0.021 CID_654 | CID_654 | |
| 0.038 | 0.611 | 0.375 | Antibacterial | 0.375 0.089 CID_654 | CID_654 | |
| 0.011 | 0.598 | 0.14 | Polo-like kinase-1 inhibitor | 0.14 0.02 CID_654 | CID_654 | |
| 0.052 | 0.651 | 0.232 | Catenin beta inhibitor | 0.232 0.015 CID_654 | CID_654 | |
| 0.012 | 0.622 | 0.134 | Lipid peroxidase inhibitor | 0.134 0.08 CID_654 | CID_654 | |
| 0.006 | 0.621 | 0.075 | Glutamate (mGluR group I) antagonist | 0.075 0.043 CID_135444498 | CID_135444498 | |
| 0.015 | 0.639 | 0.384 | Antimitotic | 0.384 0.025 CID_654 | CID_654 | |
| 0.013 | 0.638 | 0.141 | I kappa B kinase epsilon inhibitor | 0.141 0.13 CID_135444498 | CID_135444498 | |
| 0.037 | 0.68 | 0.232 | Insulysin inhibitor | 0.232 0.115 CID_135444498 | CID_135444498 | |
| 0.007 | 0.658 | 0.114 | Nitric-oxide synthase inhibitor | 0.114 0.042 CID_135444498 | CID_135444498 | |
| 0.01 | 0.667 | 0.164 | MAP kinase kinase 2 inhibitor | 0.164 0.109 CID_135444498 | CID_135444498 | |
| 0.003 | 0.665 | 0.02 | Progesterone receptor B antagonist | 0.02 0.012 CID_135444498 | CID_135444498 | |
| 0.006 | 0.686 | 0.073 | Farnesyltransferase inhibitor | 0.073 0.014 CID_654 | CID_654 | |
| 0.016 | 0.697 | 0.09 | Alpha 2d adrenoreceptor antagonist | 0.09 0.07 CID_135444498 | CID_135444498 | |
| 0.006 | 0.697 | 0.071 | ZAP-70 protein tyrosine kinase inhibitor | 0.071 0.047 CID_654 | CID_654 | |
| 0.015 | 0.712 | 0.063 | Polo-like kinase-2 inhibitor | 0.063 0.061 CID_654 | CID_654 | |
| 0.005 | 0.706 | 0.073 | Vanilloid 1 antagonist | 0.073 0.042 CID_135444498 | CID_135444498 | |
| 0.005 | 0.736 | 0.05 | Aminopeptidase N inhibitor | 0.05 0.031 CID_654 | CID_654 | |
| 0.004 | 0.752 | 0.058 | 5 Hydroxytryptamine agonist | 0.058 0.057 CID_135444498 | CID_135444498 | |
| 0.023 | 0.78 | 0.19 | Nootropic | 0.19 0.172 CID_135444498 | CID_135444498 | |
| 0.005 | 0.775 | 0.113 | Glutamate receptor antagonist | 0.113 0.082 CID_135444498 | CID_135444498 | |
| 0.005 | 0.78 | 0.068 | Aminopeptidase microsomal inhibitor | 0.068 0.033 CID_654 | CID_654 | |
| 0.004 | 0.804 | 0.089 | Protein kinase B alpha inhibitor | 0.089 0.036 CID_135444498 | CID_135444498 | |
| 0.032 | 0.888 | 0.165 | Cyclin-dependent kinase 3 inhibitor | 0.165 0.067 CID_135444498 | CID_135444498 | |
| 0.007 | 0.864 | 0.268 | Tumour necrosis factor alpha release inhibitor | 0.268 0.066 CID_654 | CID_654 | |
| 0.006 | 0.866 | 0.17 | Nicotinic acid receptor 1 agonist | 0.17 0.004 CID_135444498 | CID_135444498 | |
| 0.004 | 0.864 | 0.108 | Protein-tyrosine phosphatase 1B inhibitor | 0.108 0.071 CID_654 | CID_654 | |
| 0.05 | 0.912 | 0.209 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.209 0.14 CID_135444498 | CID_135444498 | |
| 0.003 | 0.927 | 0.058 | Cyclin B1 inhibitor | 0.058 0.047 CID_135444498 | CID_135444498 | |
| 0.004 | 0.954 | 0.097 | Cyclin B3 inhibitor | 0.097 0.03 CID_135444498 | CID_135444498 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |